When was OmnEcoil Instruments founded?

OmnEcoil Instruments was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is OmnEcoil Instruments located?

OmnEcoil Instruments is headquartered in Portland, United States.

Who is the current CEO of OmnEcoil Instruments?

Duffy DuFresne of OmnEcoil Instruments.

Is OmnEcoil Instruments a funded company?

OmnEcoil Instruments is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2018.

When was the latest funding round of OmnEcoil Instruments?

OmnEcoil Instruments' latest funding was a $***** Grant (prize money) round on Dec 15, 2020, with participation from 1 investor. Its primary sector is Oncology. In United States, the Oncology sector has seen $2.9B in funding in 2026 to date.

Where does OmnEcoil Instruments rank among its competitors?

OmnEcoil Instruments ranks 16th amongst 36 active competitors, of which 11 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Exact Imaging, which secured $10M in Feb, 2026.

Who are the top competitors of OmnEcoil Instruments?

OmnEcoil Instruments' top competitors include Profound Medical, Exact Imaging and Imaging Biometrics. Among them, Exact Imaging secured the most recent funding round in February, 2026.

OmnEcoil Instruments - 2026 Company Profile, Team, Funding & Competitors

OmnEcoil Instruments is a funded company based in Portland (United States), founded in 2016. It operates as a Developing the device for tissue sampling and prostate cancer detection. OmnEcoil Instruments has raised an undisclosed amount in funding. The company has 36 active competitors, including 11 funded and 7 that have exited. Its top competitors include companies like Profound Medical, Exact Imaging and Imaging Biometrics.

Company Details

The OmnEcoil is developing the device for tissue sampling and prostate cancer detection. It's endorectal coil embedded in the device that allows better needle placement for the biopsy sampling without prostrate deformation.

Key Metrics

Founded Year

2016

Location

Portland, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Dec 15, 2020, $*****

Investors

National Science Foundation & 3 more

Ranked

16^th among 36 active competitors

Similar Companies

AIdoc & 360 more

View OmnEcoil Instruments' full profile

OmnEcoil Instruments has raised funding over 2 rounds. Its first funding round was on Jan 01, 2018. Its latest funding round was a Grant (prize money) round on Dec 15, 2020 for $*****. 1 investor participated in its latest round. OmnEcoil Instruments has 4 institutional investors.

Here is the list of recent funding rounds of OmnEcoil Instruments:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 15, 2020	9918094	Grant (prize money)	9546838	5796871	6559167	8137168
Jan 01, 2018	9246500	Grant (prize money)	1313228	6840019	6387313	National Science Foundation

Access funding benchmarks and valuations. Sign up today!

View details of OmnEcoil Instruments's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of OmnEcoil Instruments include Profound Medical, Exact Imaging and Imaging Biometrics. Here is the list of Top 10 competitors of OmnEcoil Instruments, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Profound Medical 2008, Toronto (Canada), Public	Developer of image guided prostate ablation system for cancer treatment	$37.7M	Genesys Capital, BDC & 11 others	65/100
2nd	Exact Imaging 2013, Markham (Canada), Series D	Developer of micro-ultrasound based imaging device	$39.9M	iGan Partners, Lumira Ventures & 9 others	57/100
3rd	Imaging Biometrics 2007, Waukesha (United States), Acquired	Provider of an AI-based medical image analysis software for healthcare professionals	$24.1K	National Cancer Institute, Braveheart Investment Group ... & 3 others	52/100
4th	KOELIS 2006, Meylan (France), Acquired	Developer of MRI/Ultrasound fusion biopsy system for personalized prostate care	-	MEDEVICE	49/100
5th	BotImage 2019, Omaha (United States), Seed	Provider of AI-based image interpretation for MRI for prostrate cancer detection	$4.34M	-	47/100
6th	DynamX Medical 2015, Didcot (United Kingdom), Seed	Provider of a biopsy screening medical device targeting cancer and other diseases	$3.4M	Pemco, Reyker & 31 others	46/100
7th	MeVis 1997, Bremen (Germany), Acquired	Provides image processing software and services for cancer screening	-	-	44/100
8th	Kuva Labs 2024, Royal Oak (United States), Unfunded	Platform offering solutions for cancer diagnostics	-	-	42/100
9th	CureMetrix 2014, Rancho Santa Fe (United States), Seed	Detection of breast cancer in mammograms using medical image analytics	-	EvoNexus, Bold Brain & 6 others	41/100
10th	Linking Med 2016, Beijing (China), Series A	Medical data analysis platform for tumors	$7.51M	DHVC, Linear Venture & 7 others	40/100
16th	OmnEcoil Instruments 2016, Portland (United States), Funding Raised	Developing the device for tissue sampling and prostate cancer detection	-	National Science Foundation, America’s Seed Fund ... & 2 others	31/100